Patents by Inventor Christian Heidbreder

Christian Heidbreder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11000520
    Abstract: The disclosure provides a dosage regimen using sustained-release buprenorphine formulations to produce therapeutic levels of buprenorphine in patients for the treatment of pain or opioid use disorders.
    Type: Grant
    Filed: November 6, 2015
    Date of Patent: May 11, 2021
    Assignee: Indivior UK Limited
    Inventors: Azmi Nasser, Celine M Laffont, Christian Heidbreder
  • Publication number: 20190046532
    Abstract: The disclosure provides methods for treating psychiatric diseases, such as schizophrenia, in patients with certain gene polymorphisms using antipsychotic drugs, such as risperidone and paliperidone.
    Type: Application
    Filed: September 29, 2016
    Publication date: February 14, 2019
    Inventors: Zacharoula Konsoula, John Parick Jones, Philip Twumasi-Ankrah, Christian Heidbreder, Azmi Nasser
  • Publication number: 20190015415
    Abstract: The disclosure provides methods for treating psychiatric diseases, such as schizophrenia, in patients with certain gene polymorphisms using antipsychotic drugs, such as risperidone and paliperidone.
    Type: Application
    Filed: August 10, 2018
    Publication date: January 17, 2019
    Inventors: Zacharoula Konsoula, John Patrick Jones, Philip Twumasi-Ankrah, Christian Heidbreder, Azmi Nasser
  • Publication number: 20120196910
    Abstract: The present invention provides a new use of a compound of formula (I) or a pharmaceutically acceptable salt or solvate salt thereof: for the treatment of a somatoform disorder such as body dysmorphic disorder or hyperchondriasis, bulimia nervosa, anorexia nervosa, binge eating, paraphilia and nonparaphilic sexual addictions, Sydeham's chorea, torticollis, autism, a movement disorder including Tourette's syndrome.
    Type: Application
    Filed: March 28, 2012
    Publication date: August 2, 2012
    Inventors: Dieter HAMPRECHT, Christian Heidbreder, Sergio Melotto, Fabrizio Micheli, Tadataka Yamada
  • Publication number: 20090036461
    Abstract: The present invention provides a new use of a compound of formula (I) or a pharmaceutically acceptable salt or solvate salt thereof: wherein: G is selected from a group consisting of: phenyl, pyridyl, benzothiazolyl, indazolyl; p is an integer ranging from 0 to 5; R1 is independently selected from a group consisting of: halogen, hydroxyl, cyano, C1-4alkyl, haloC1-4alkyl, C1-4alkoxy, haloC1-4alkoxy, C1-4alkanoyl; or corresponds to a group R5; R2 is hydrogen or C1-4alkyl; R3I s C1-4alkyl; R4 is hydrogen, or a phenyl group, a heterocyclyl group, a 5- or 6-membered heteroaromatic group, or a 8- to 11-membered bicyclic group, any of which groups is optionally substituted by 1, 2, 3 or 4 substituents selected from the group consisting of: halogen, cyano, C1-4alkyl, haloC1-4alkyl, C1-4alkoxy, C1-4alkanoyl; R5 is a moiety selected from the group consisting of: isoxazolyl, —CH2—N-pyrrolyl, 1,1-dioxido-2-isothiazolidinyl, thienyl, thiazolyl, pyridyl, 2-pyrrolidinonyl, and such a group is optionally substituted by
    Type: Application
    Filed: August 21, 2006
    Publication date: February 5, 2009
    Inventors: Dieter Hamprecht, Christian Heidbreder, Sergio Melotto, Fabrizio Micheli, Tadataka Yamada